New phase II trial opens in France to study XAV-19 in COVID-19-induced moderate pneumonia Sep. 21, 2020
ImmTAV molecules redirect T cells to lyse HBV DNA-integrated and virally infected cells in vitro Sep. 21, 2020
New phase II trial investigates fostamatinib for treatment of hospitalized COVID-19 patients Sep. 18, 2020
Phase III EMPACTA trial of Actemra in COVID-19-associated pneumonia meets primary endpoint Sep. 18, 2020
RSS